Mary F. Hoult

Mary F. Hoult

Plus aucun poste en cours

58 ans
Commercial Services
Health Technology
Consumer Services

Profil

Ms. Molly Hoult is a Principal at Fletcher Spaght Venture Partners LLC and Independent Director at HTG Molecular Diagnostics, Inc. She is on the Board of Directors at Fletcher Spaght, Inc. and HTG Molecular Diagnostics, Inc. Prior to rejoining the firm in 2009, Ms. Hoult spent over a decade in marketing and business development roles for various biotechnology and medical device firms including: ZymoGenetics, Blue Heron Biotechnology and NeoPath (which subsequently merged to form TriPath and then was acquired by BD Diagnostics).
Ms. Hoult holds an MBA from the Stanford Graduate School of Business and a BA in Biology and Environmental Studies from Dartmouth College.

Anciens postes connus de Mary F. Hoult

SociétésPosteFin
Promidian Private Equity Investor 01/09/2021
Private Equity Investor 01/09/2021
Private Equity Investor 01/04/2019
HTG MOLECULAR DIAGNOSTICS, INC. Directeur/Membre du Conseil 01/08/2016
Xcyte Therapies, Inc. Directeur/Membre du Conseil -
Voir l'expérience en détail de Mary F. Hoult

Formation de Mary F. Hoult

Dartmouth College Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mary F. Hoult

Relations

24

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
HTG MOLECULAR DIAGNOSTICS, INC.

Commercial Services

Entreprise privées7

Health Technology

Commercial Services

Xcyte Therapies, Inc.

Health Technology

Health Technology

Commercial Services

Commercial Services

Promidian

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mary F. Hoult